SSofie· Business · 12 sources · 1dStoryGE HealthCare Plans $945 Million SOFIE AcquisitionGE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash, expanding its U.S. PET radiopharmaceutical manufacturing and distribution network and strengthening its position in the growing precision-imaging market. The deal, expected to close in the first half of 2027 pending regulatory approval, also gives GE HealthCare U.S. rights to the Phase III imaging agent FAPI-74.Business· 1d+90CommentShareWrite a comment…
SSofie· Business · 8 sources · Sep 13, 2026StoryGE HealthCare reportedly nears $1B Sofie Biosciences acquisitionGE HealthCare is in advanced talks to acquire Sofie Biosciences for about $1 billion, a move to bolster its Pharmaceutical Diagnostics division by owning the consumable radiopharmaceuticals used with PET scans and to accelerate its radiopharmacy network. The deal would cement recurring revenue from radiotracers and link Sofie’s pipeline to GE HealthCare’s scanner business, potentially expediting access to Sofie’s innovative FAPI programs.Business· Sep 13, 2026+5+12ShareDerek Foss·Sep 13, 2026Top commentSofie’s pipeline looks promising but a billion-dollar price tag is steep for what is still early-stage tech.00ReplyGenius replyShareWrite a comment…
